Revisiting regulatory framework in India for accelerated vaccine development in pandemics with an evidence-based fast-tracking strategy.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Medknow Country of Publication: India NLM ID: 0374701 Publication Model: Print Cited Medium: Internet ISSN: 0971-5916 (Print) Linking ISSN: 09715916 NLM ISO Abbreviation: Indian J Med Res Subsets: MEDLINE
    • Publication Information:
      Publication: <2011- > : Mumbai : Medknow
      Original Publication: New Delhi : Council Of Medical Research
    • Subject Terms:
      COVID-19 Vaccines*; COVID-19/*prevention & control ; Drug Discovery/*trends ; Pandemics/*prevention & control ; Vaccines/*immunology; Biomedical Research ; Drug Approval ; Humans ; India/epidemiology ; SARS-CoV-2 ; Time Factors ; Viral Vaccines
    • References:
      Nature. 2020 Apr 30;:. (PMID: 32355243)
      Trends Pharmacol Sci. 2020 Jun;41(6):363-382. (PMID: 32291112)
      Health Res Policy Syst. 2020 Jun 8;18(1):61. (PMID: 32513202)
      N Engl J Med. 2020 May 21;382(21):1969-1973. (PMID: 32227757)
      Trends Biotechnol. 2020 Sep;38(9):943-947. (PMID: 32600777)
    • Accession Number:
      0 (COVID-19 Vaccines)
      0 (Vaccines)
      0 (Viral Vaccines)
    • Publication Date:
      Date Created: 20200921 Date Completed: 20210225 Latest Revision: 20210225
    • Publication Date:
      20240104
    • Accession Number:
      PMC7853266
    • Accession Number:
      10.4103/ijmr.IJMR_3640_20
    • Accession Number:
      32952146